Barchart is a leading provider of market data and services to the global financial, media, and commodity industries. From our interactive charting library, through to our leading financial analysis desktops, we connect you to the content you need.
| Period | Period Low | Period High | Performance | |
|---|---|---|---|---|
| 1-Month | 235.23 unch on 05/30/17 | | 238.20 -1.25% on 05/26/17 | +0.43 (+0.18%) since 04/28/17 |
| 3-Month | 231.40 +1.66% on 03/01/17 | | 238.20 -1.25% on 05/26/17 | +3.83 (+1.66%) since 02/28/17 |
| 52-Week | 224.00 +5.01% on 11/15/16 | | 238.20 -1.25% on 05/26/17 | +5.83 (+2.54%) since 05/27/16 |
These penny stocks are positioned in high-growth sectors, offering strong long-term potential. Plus, most analysts have given them a 'Strong Buy' rating.
Following a disappointing fiscal Q1 earnings report, FDX stock tanked. Still, with the global courier now trading at a discount, it entices smart speculation.
/Idex%20Corporation%20logo%20and%20lab%20sign-by%20viewimage%20via%20Shutterstock.jpg)
IDEX Corporation has struggled to keep up with the Dow Jones index over the past year, but analysts are moderately bullish on the stock's potential.
/Quest%20Diagnostics%2C%20Inc_%20sign-%20by%20Sundry%20Photogreaphy%20via%20Shutterstock.jpg)
Quest Diagnostics has outperformed the broader healthcare sector recently, and analysts are bullish about the stock's future.
Despite Camden Property’s underperformance relative to the Nasdaq Composite over the past year, Wall Street analysts remain moderately optimistic about the stock’s prospects.
/Akamai%20Technologies%20Inc%20logo%20on%20building-by%20Sundry%20Photography%20via%20Shutterstock.jpg)
Despite Akamai Technologies’ underperformance relative to the Nasdaq Composite over the past year, Wall Street analysts remain moderately bullish about the stock’s prospects.
Although Healthpeak Properties has underperformed the Dow Jones Industrials Average over the past year, Wall Street analysts maintain a moderately optimistic outlook on the stock’s prospects.
/Walgreens%20Boots%20Alliance%20Inc%20store-%20by%20Sundry%20Photography%20via%20Shutterstock.jpg)
As Walgreens Boots Alliance underperformed the healthcare sector, Wall Street analysts remain cautious about the stock’s prospects.
/Carmax%20Inc%20storefront%20by-jetcityimage%20via%20iStock.jpg)
Despite CarMax’s underperformance relative to the S&P 500 Index over the past year, Wall Street analysts remain moderately optimistic about the stock’s prospects.
/Allegion%20plc%20chart%20and%20logo%20on%20phone-by%20Piotr%20Swat%20via%20Shutterstock.jpg)
Allegion outperformed the broader sector recently, but Wall Street analysts remain cautious about the stock’s prospects.
| Symbol | Last | Change |
|---|---|---|
| I8K17 | 235.23s | -2.97 |
| HPI San Francisco May '17 | ||
| I8G25 | 359.40s | unch |
| HPI San Francisco | ||
| ESZ24 | 5,767.50 | +5.50 |
| S&P 500 E-Mini | ||
| NQZ24 | 20,042.50 | +14.25 |
| Nasdaq 100 E-Mini | ||
| YMZ24 | 42,471 | +28 |
| Dow Futures Mini | ||
| QRZ24 | 2,243.90 | -8.70 |
| Russell 2000 E-Mini | ||
| EWZ24 | 3,149.00 | +16.10 |
| S&P Midcap E-Mini | ||
| ETZ24 | 5,767.50 | +5.50 |
| S&P 500 Micro | ||
| NMZ24 | 20,042.75 | +14.50 |
| Nasdaq 100 Micro | ||
| VIV24 | 18.1500 | +0.1958 |
| S&P 500 VIX | ||
| GDV24 | 531.15 | -2.00 |
| S&P GSCI | ||
| AHZ24 | 98.93 | +0.77 |
| Bloom Commodity Index | ||
| 3rd Resistance Point | N/A |
| 2nd Resistance Point | 235.23 |
| 1st Resistance Point | 235.23 |
| Last Price | 235.23s |
| 1st Support Level | 235.23 |
| 2nd Support Level | 235.23 |
| 3rd Support Level | N/A |
| 52-Week High | 238.20 |
| Last Price | 235.23s |
| Fibonacci 61.8% | 232.78 |
| Fibonacci 50% | 231.10 |
| Fibonacci 38.2% | 229.42 |
| 52-Week Low | 224.00 |
